Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites

News Daily News

TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites

Michael O'Riordan

February 13, 2024

Top Five Online Resources for Fellows Pursuing Interventional Cardiology

News Opinion Fellow Talk

Top Five Online Resources for Fellows Pursuing Interventional Cardiology

October 28, 2021

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

News Opinion Fellow Talk

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Yashasvi Chugh, MD

August 05, 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

May 16, 2019

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

Nirmanmoh Bhatia, MD

News Featured Fellow

Nirmanmoh Bhatia, MD

Yael L. Maxwell

July 11, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.